Skip to content
  • Home
  • Our Mission
  • The Solution
  • Clinical Trials
  • Media
  • Clinical Development
  • Our Team
  • Contact Us
Menu
  • Home
  • Our Mission
  • The Solution
  • Clinical Trials
  • Media
  • Clinical Development
  • Our Team
  • Contact Us

Peer Reviews

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson’s disease and multiple system atrophy

Acetyl-L-Carnitine Deficiency in Patients with Major Depressive Disorder

A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

Effect of intranasally administered insulin on cerebral blood flow and perfusion

Johns Hopkins: Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer’s Disease Dementia, Phase I

Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes

Intranasal insulin: is there a promise for treatment of diabetes-related cognitive decline?

Acute Effects of Intranasal Insulin on Regional Cerebral Perfusion and Cognition in Type 2 Diabetes

Intranasal Insulin Therapy for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

Posts pagination
1 2 Next Page →
Facebook-f Twitter Linkedin-in Instagram Youtube

Copyright © 2023 Kurve Therapeutics

  • Home
  • Our Mission
  • The Solution
  • Clinical Trials
  • Media
  • Clinical Development
  • Our Team
  • Contact Us
  • Home
  • Our Mission
  • The Solution
  • Clinical Trials
  • Media
  • Clinical Development
  • Our Team
  • Contact Us